MIT team uses an AI algorithm to screen excipient ratios, yielding RNA vaccines that stay stable for a year at room temperature or two months at 37 C and still match a Moderna-like vaccine's immune response in mice
Working with MIT's CSAIL, researchers developed a machine-learning algorithm that predicts from very small datasets, used it to screen nearly 50 FDA-approved excipients and predict excipient ratios for the lipid nanoparticle (LNP) formulations used by the Moderna and Pfizer Covid-19 vaccines, and produced vaccines that after vacuum drying remained stable for two months at 37 C (about 98 F) or one year at room temperature while generating immune responses in mice equivalent to those from a vaccine carried by LNPs similar to the original Moderna formulation, and also built solid microneedle patches that produced similar immune responses.